These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29751051)

  • 1. Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis.
    Pievsky MA; McGrath RE
    Neurosci Biobehav Rev; 2018 Jul; 90():447-455. PubMed ID: 29751051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: Dose-Dependent Effects of Methylphenidate on Neurocognitive Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
    Vertessen K; Luman M; Staff A; Bet P; de Vries R; Twisk J; Oosterlaan J
    J Am Acad Child Adolesc Psychiatry; 2022 May; 61(5):626-646. PubMed ID: 34534624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
    Geladé K; Bink M; Janssen TW; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.
    Tucha O; Mecklinger L; Laufkötter R; Klein HE; Walitza S; Lange KW
    J Neural Transm (Vienna); 2006 Oct; 113(10):1575-92. PubMed ID: 16897610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.
    Blum NJ; Jawad AF; Clarke AT; Power TJ
    Dev Med Child Neurol; 2011 Sep; 53(9):843-849. PubMed ID: 21585365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
    Buitelaar JK; Sobanski E; Stieglitz RD; Dejonckheere J; Waechter S; Schäuble B
    J Clin Psychiatry; 2012 Aug; 73(8):1097-102. PubMed ID: 22780962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.
    Coghill DR; Seth S; Pedroso S; Usala T; Currie J; Gagliano A
    Biol Psychiatry; 2014 Oct; 76(8):603-15. PubMed ID: 24231201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder.
    McInnes A; Bedard AC; Hogg-Johnson S; Tannock R
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):35-49. PubMed ID: 17343552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
    Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to methylphenidate in boys with attention-deficit hyperactivity disorder.
    Zeiner P; Bryhn G; Bjercke C; Truyen K; Strand G
    Acta Paediatr; 1999 Mar; 88(3):298-303. PubMed ID: 10229041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.